Serina Therapeutics, Inc.
SERNYSECIK 1708599HealthcareFiscal year ends Dec 31
Reports and events: 240 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-0921:19 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001708599-26-000060 |
| 2026-09-0911:43 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001708599-26-000054 |
| 2026-08-2722:24 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001708599-26-000051 |
| 2026-08-2421:24 ET | S-1 | Registration statement | 0001493152-26-039910 |
| 2026-08-1320:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001708599-26-000048 |
| 2026-08-1320:03 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001708599-26-000047 |
| 2026-07-2320:51 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001628280-26-049426 |
| 2026-07-2221:03 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001708599-26-000043 |
| 2026-07-2216:12 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001104659-26-085696 |
| 2026-06-2420:10 ET | 8-K | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results | 0001708599-26-000040 |
| 2026-05-1420:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001708599-26-000036 |
| 2026-05-1420:03 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001708599-26-000035 |
| 2026-04-2720:24 ET | DEF 14A | Proxy statementPeriod 2026-04-27 | 0001708599-26-000029 |
| 2026-04-2121:12 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws | 0001708599-26-000027 |
| 2026-03-2717:57 ET | 10-K/A | Annual report, amendedPeriod 2025-12-31 | 0001708599-26-000022 |
| 2026-03-2520:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001708599-26-000018 |
| 2026-03-2520:03 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001708599-26-000016 |
| 2026-03-2320:07 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001708599-26-000010 |
| 2026-01-2821:03 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001708599-26-000005 |
| 2026-01-1521:03 ET | 8-K | 3.01 Delisting notice; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001708599-26-000003 |
| 2025-12-1021:17 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001708599-25-000138 |
| 2025-11-1311:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001708599-25-000135 |
| 2025-11-1311:03 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001708599-25-000133 |
| 2025-11-1217:36 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001708599-25-000130 |
| 2025-11-0311:03 ET | 8-K | 8.01 Other events | 0001708599-25-000126 |
| 2025-10-0620:12 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001708599-25-000122 |
| 2025-09-2615:29 ET | DEF 14A | Proxy statementPeriod 2025-09-26 | 0001708599-25-000115 |
| 2025-09-1520:01 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001708599-25-000110 |
| 2025-09-0919:23 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001708599-25-000108 |
| 2025-08-2520:03 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001708599-25-000105 |
| 2025-08-2220:07 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001708599-25-000101 |
| 2025-08-1120:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001708599-25-000091 |
| 2025-08-1120:05 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001708599-25-000089 |
| 2025-07-2910:03 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001708599-25-000076 |
| 2025-07-0120:02 ET | 8-K | 5.08 Item not in the standard list; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001708599-25-000065 |
| 2025-05-2220:40 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001708599-25-000058 |
| 2025-05-0820:12 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001708599-25-000055 |
| 2025-05-0820:10 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001708599-25-000053 |
| 2025-04-2920:33 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001708599-25-000048 |
| 2025-04-1510:33 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001708599-25-000044 |
| 2025-04-1420:28 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001708599-25-000042 |
| 2025-04-0710:33 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001708599-25-000033 |
| 2025-03-2420:20 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001708599-25-000029 |
| 2025-03-2420:14 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001708599-25-000027 |
| 2025-03-2410:37 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001708599-25-000023 |
| 2025-02-1221:04 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001708599-25-000016 |
| 2025-02-0321:05 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001708599-25-000013 |
| 2025-01-1522:37 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001708599-25-000005 |
| 2025-01-0621:07 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001708599-25-000002 |
| 2024-12-2600:50 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits | 0001708599-24-000033 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:07 ET. Listed shows no prices and gives no investment advice.